Position in EOLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,297,694
-$7,950,594 QoQ
Shares Held
559,050
-63.7% QoQ
Ownership
0.849%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $613,305,594 across 42 Drug Manufacturers - Specialty & Generic names. EOLS ranks #31 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
99,106 | $58,767,875 | |
| 2 | VTRS |
Viatris Inc
|
3,882,541 | $52,453,128 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,602,543 | $48,199,096 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
959,257 | $46,188,223 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,788,811 | $45,175,103 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
1,982,724 | $44,809,561 | |
| 7 | LQDA |
Liquidia Corp
|
873,065 | $32,949,472 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
622,450 | $32,174,439 |
All Filings in EOLS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,297,694 | 559,050 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,248,288 | 1,541,096 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,315,984 | 1,354,395 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,820,794 | 957,741 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,551,043 | 877,061 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,363,862 | 848,176 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,718,373 | 970,270 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,451,413 | 871,098 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $13,686,092 | 977,578 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,460,904 | 708,538 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,512,243 | 493,681 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,154,853 | 158,852 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,543,128 | 182,403 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,147,919 | 286,008 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,603,022 | 323,357 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,325,781 | 545,326 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,428,660 | 662,091 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,558,991 | 700,306 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,015,627 | 658,219 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,329,629 | 500,366 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,121,240 | 163,298 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||